BioLargo Balance Sheet Health
Financial Health criteria checks 6/6
BioLargo has a total shareholder equity of $4.2M and total debt of $589.0K, which brings its debt-to-equity ratio to 14%. Its total assets and total liabilities are $8.2M and $4.0M respectively.
Key information
14.0%
Debt to equity ratio
US$589.00k
Debt
Interest coverage ratio | n/a |
Cash | US$3.54m |
Equity | US$4.20m |
Total liabilities | US$4.00m |
Total assets | US$8.21m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BLGO's short term assets ($6.4M) exceed its short term liabilities ($2.7M).
Long Term Liabilities: BLGO's short term assets ($6.4M) exceed its long term liabilities ($1.3M).
Debt to Equity History and Analysis
Debt Level: BLGO has more cash than its total debt.
Reducing Debt: BLGO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLGO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BLGO has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 6.3% each year.